SIETES :: 93082 citas

Resultados de la búsqueda por USA REFINAR BÚSQUEDA

1.

Samper E. Laboratorios y Estados invierten miles de millones y se lanzan a la producción masiva de vacunas experimentales sin certezas sobre su eficacia. eldiario.es 2020:29 de julio. [Ref.ID 103703]

2.

Parsons L. Novavax reports promising phase 1 results for coronavirus vaccine. PMLiVE 2020:5 de agosto. [Ref.ID 103702]

3.

Parsons L. US secures 100 million doses of Sanofi/GSK’s COVID-19 vaccine. PMLiVE 2020:3 de agosto. [Ref.ID 103701]

4.

Parsons L. Moderna looks to price COVID-19 vaccine at $50-$60 per course. PMLiVE 2020:29 de julio. [Ref.ID 103700]

5.

Parsons L. US government pays $1.95bn for Pfizer/BioNTech’s COVID-19 vaccine. PMLiVE 2020:23 de julio. [Ref.ID 103697]

6.

Arshad S, Kilgore P, Chaudhry ZS, Jacobsen G, Wang DD, Huitsing K, Brar I, Alangaden GJ, Ramesh MS, McKinnon JE, O'Neill W, Zervos M, Henry Ford COVID-19 Task Force. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. International Journal of Infectious Diseases 2020:1 de julio. [Ref.ID 103682]

7.

Moynihan R, MacDonald H, Bero L, Godlee F. Commercial influence and covid-19. BMJ 2020;369:24 de junio. [Ref.ID 103680]

8.

EC. El remdesivir ya tiene precio: 2.340 dólares por un tratamiento contra el covid. El Confidencial 2020:29 de junio. [Ref.ID 103676]

9.

Zaroff JG, Cheetham TC, Palmetto N, Almers L, Quesenberry C, Schneider J, Gatto N, Corley DA. Association of azithromycin use with cardiovascular mortality. JAMA Network Open 2020;3:17 de junio. [Ref.ID 103669]

10.

Anónimo. Coronavirus (COVID-19) Update: FDA revokes emergency use authorization for chloroquine and hydroxychloroquine. U.S. Food and Drug Administration 2020:1. [Ref.ID 103663]

11.

Rome BN, Avorn J. Drug evaluation during the covid-19 pandemic. N Engl J Med 2020;382:11 de junio. [Ref.ID 103661]

12.

Moynihan R, Albarqouni L, Nangla C, Dunn AG+, Lexchin J, Bero L. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study. BMJ 2020;369:27 de mayo. [Ref.ID 103650]

13.

Niznik JD, Zhao X, He M, Aspinall SL, Hanlon JT, Hanson LC, Nace D, Thorpe JM, Thorpe CT. Risk for health events after deprescribing acetylcholinesterase inhibitors in nursing home residents with severe dementia. J Am Geriatr Soc 2020;68:699-707. [Ref.ID 103640]

14.

Anónimo. In brief: Neuropsychiatric events with montelukast. Med Lett Drugs Ther 2020;62:65. [Ref.ID 103638]

15.

Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, et al. for the ACTT-1 Study Group Members. Remdesivir for the treatment of covid-19 — Preliminary report. N Engl J Med 2020:22 de mayo. [Ref.ID 103631]

16.

Esse S, Mason KJ, Green AC, Warren RB. Melanoma risk in patients treated with biologic therapy for common inflammatory diseases. A systematic review and meta-analysis. JAMA Dermatol 2020:20 de mayo. [Ref.ID 103629]

17.

Zhu H, Bateman BT, Gray KJ, Hernandez-Diaz S, Mogun H, Starub L, Huybrechts KF. Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study. BMJ 2020;369:20 de mayo. [Ref.ID 103628]

18.

Nici L, Mammen MJ, Charbek E, Alexander PE, Au DH, Boyd C, Criner GJ, Donaldson GC, Dreher M, Fan VS, Gershon AS, et al.. Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline . Am J Respir Crit Care Med 2020;201:1 de mayo. [Ref.ID 103620]

19.

Corbella J. La primera vacuna de la Covid ensayada en personas muestra eficacia. La Vanguardia 2020:19 de mayo. [Ref.ID 103619]

20.

Samper E. Lo que el dinero no puede acelerar: ¿Por qué requiere tanto tiempo conseguir una vacuna contra el coronavirus? . eldiario.es 2020:9 de mayo. [Ref.ID 103617]